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Background: The resumption of menses (ROM) is considered an important clinical marker in weight restoration for
patients with anorexia nervosa (AN). The purpose of this study was to examine ROM in relation to expected body
weight (EBW) and psychosocial markers in adolescents with AN.
Methods: We conducted a retrospective chart review at The University of Chicago Eating Disorders Program from
September 2001 to September 2011 (N = 225 females with AN). Eighty-four adolescents (Mean age = 15.1, SD = 2.2)
with a DSM-IV diagnosis of AN, presenting with secondary amenorrhea were identified. All participants had received
a course of outpatient family-based treatment (FBT), i.e., ~20 sessions over 12 months. Weight and menstrual status
were tracked at each therapy session throughout treatment. The primary outcome measures were weight (percent
of expected for sex, age and height), and ROM.
Results: Mean percent EBW at baseline was 82.0 (SD = 6.5). ROM was reported by 67.9% of participants (57/84), on
average at 94.9 (SD = 9.3) percent EBW, and after having completed an average of 13.5 (SD = 10.7) FBT sessions
(~70% of standard FBT). Compared to participants without ROM by treatment completion, those with ROM had
significantly higher baseline Eating Disorder Examination Global scores (p = .004) as well as Shape Concern (p < .008)
and Restraint (p < .002) subscale scores. No other differences were found.
Conclusions: Results suggest that ROM occur at weights close to the reference norms for percent EBW, and that
high pre-treatment eating disorder psychopathology is associated with ROM. Future research will be important to
better understand these differences and their implications for the treatment of adolescents with AN.
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Anorexia nervosa (AN) is a serious disorder that is associ-
ated with numerous medical and psychiatric complications
[1-6]. AN typically onsets during adolescence [7], and is as-
sociated with delayed menarche in premenarchal females,
or amenorrhea in postmenarchal females [8]. Amenorrhea,
defined as the lack of three consecutive menstrual periods
in postmenarchal females, is one of four criteria for AN in
the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition Text revision (DSM-IV-TR) [9] and is cur-
rently considered a key clinical feature of AN. However, in
anticipation of DSM-5, there has been considerable debate* Correspondence: legrange@uchicago.edu
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reproduction in any medium, provided the orregarding whether amenorrhea is a useful criterion [10],
especially as it applies to children and younger adolescents,
females on contraceptives, and males. The DSM-IV-TR
does not consider primary amenorrhea (i.e., failure of men-
ses to start by age 15 while secondary sex characteristics
such as breast development and growth of body hair are
present, or within three years of the onset of secondary
sexual characteristics) as part of the criteria for females with
AN [11]. Further, a significant proportion of female adoles-
cents with AN continue to menstruate at low weights [12],
while minimal differences have been found between amen-
orrheic and menstruating individuals on clinically relevant
variables such as length of illness (LOI), eating-related
psychopathology, number of previous hospitalizations, and
discharge weight [10].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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status as a measure of physiological health highlights the
need for the early identification of serious medical issues
[13], such as aberrations in metabolism, structural and
functional brain alterations [14], and cardiovascular com-
plications [15]. Importantly, individuals with amenorrhea
achieve lower peak bone mass levels than age-matched
controls [16,17]. It has been shown that pre-pubertal
weight can be a useful tool to determine the weight at
which resumption of menses (ROM) is likely to occur in
adolescents with AN, highlighting the need to return to a
weight trajectory preceding weight loss [18]. Conversely,
ROM may be used as a key marker of recovery from AN
as it is associated with return of physical health. For
example, ROM in conjunction with weight gain has been
found to correlate with increased bone mineral density in
patients with AN [19,20]. It is important to consider
several factors when estimating treatment goal weights in
pediatric eating disorders. Goal weights typically take into
account patient’s height, age, premorbid growth curve
percentiles for height and weight, prior growth trajectory,
growth potential, pubertal stage, anthropometric measure-
ments and other physiological factors [1]. However, ROM
does not only depend on reaching goal weight, as endo-
crine markers such as luteinizing hormone, estradiol, and
triiodothyronine can also be useful in determining the on-
set or return of menses [3,18,21,22]. Notwithstanding,
ROM, in conjunction with expected body weight (EBW),
can serve as a yardstick to estimate goal weights for
adolescent AN. In an elegant study of 100 adolescents
with AN, menstruation resumed on average at 91.6%
median weight for age and height. At one-year follow-up,
68% of participants resumed menses, and overall, 86%
resumed menses within six months of achieving this weight
[23]. It is of interest to note that 73% (16/22) of patients
who remained amenorrheic did achieve a weight high
enough to presumably resume menses. Using ROM in
the context of EBW may predict more accurately
return to health for patients with AN rather than
using goal weight ranges alone. However, what differ-
entiates patients at a minimally healthy weight with
and without ROM remains unclear.
Overall, this study aimed to identify correlates of
ROM that may assist clinicians with treatment planning.
Our primary goal was to detect mean percent EBW and
time point during a course of outpatient family-based
treatment (FBT; the most well-established treatment for
adolescent AN) [24] at which ROM occurs for adoles-
cent AN. Our secondary goal was to examine demo-
graphic and psychosocial characteristics associated with
ROM. As the relationship between amenorrhea and psy-
chosocial variables remains unclear, we did not expect
any differences between patients with and without ROM
in terms of psychosocial characteristics at baselineevaluation [10,25]. We did, however, anticipate that patients
with binge/purge behaviors would be more likely to resume
menses during treatment than patients without such behav-
iors. Our hypothesis was informed by a study of 197 indi-
viduals treated at and inpatient eating disorders program
comparing menstrual status (menstruating vs. amenorrheic)
and AN subtype (restricting vs. binge/purge), which found
a significantly higher number of patients who were
menstruating to have the binge/purge subtype [10].
Methods
Participants
Potential participants were 225 females with AN, aged
11–20 years, presenting for treatment at the Eating
Disorders Program at The University of Chicago between
September 2001 and September 2011. Of those, 47 were
prepubertal or presented with primary amenorrhea, 56 had
regular or irregular periods, 27 were taking oral contracep-
tives, and 11 did not provide this information. Therefore,
84 females with secondary amenorrhea, meeting DSM-IV
criteria for AN or partial AN were included in the current
study. Partial AN was defined as <90% EBW and was in-
cluded as many young patients with eating disorders do not
fit criteria used for adults, while being at risk for developing
significant health complications following less severe weight
loss than might be typical among adult populations [26-28].
EBW is one method used to set appropriate treatment goal
weights in eating disorder patients [8], and defines the opti-
mal weight for height and/or age in order to achieve
healthy nutritional status with the lowest rate of mortality
[29]. Calculation of percent EBW is not standardized across
studies with various methods leading to sizable discrepan-
cies within cases [30]. For the present study the Body Mass
Index (BMI) Method was used, which for a given subject is
based on height, age, and sex. The 50th percentile BMI for
exact age and height at presentation, as measured by the
Centers for Disease Control and Prevention growth charts
[31], was used for this calculation (%EBW=BMI/50th
percentile BMI for age and height x 100). Growth over the
course of treatment was measured to obtain accurate EBW
at ROM and end of treatment time points [32].
Measures
The Eating Disorder Examination (EDE) is a semi-
structured diagnostic interview assessing the frequency
and severity of eating disorder behaviors and cognitions
[33]. The EDE generates four subscale scores as well as a
composite global score. Scores range from 0 to 6, with
higher scores indicating greater severity of eating disorder
symptoms. The EDE was used in this study to generate
diagnoses, determine baseline menstrual status, and assess
eating disorder symptoms. Demographic information and
history of prior medical and/or psychiatric hospitalizations
were obtained from a diagnostic interview. Weight and
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respectively. In this study ROM was defined as at least one
spontaneous menstrual cycle while in treatment.
Procedure
The Institutional Review Board at The University of
Chicago approved this research. Written assent and/or con-
sent were obtained from each patient and parent/guardian,
where appropriate (i.e., assent if patient was <18 years). All
patients received manualized FBTadministered by a trained
clinician in our program. FBT has received robust research
support [34], and is a manualized treatment that focuses on
enlisting the parents, guided by the therapist, in facilitating
weight restoration for the ill child, and is typically delivered
in 20 sessions over 12 months [24]. Patients, in light
indoor clothing, were weighed by their therapist at
the outset of each treatment session and asked to
self-report menstrual status.
Statistical analysis
Descriptive statistics were used to examine percent EBW
and FBT session at which ROM occurred. Independent
samples t-tests were used to compare patients with full
versus partial AN in age, illness duration, eating disorder
psychopathology, and weight gained during treatment.
AN cases were compared to partial AN to test whether
(a) these two groups were broadly comparable, and (b)
ensure that differences between patients with or without
ROM were not due to diagnosis. Chi-square tests were
used to examine differences between AN and partial AN in
terms of previous medical and/or psychiatric hospitaliza-
tions and ethnicity. In addition, independent samples t-tests
were conducted to determine baseline differences in age,
percent EBW, BMI, LOI, average amount of weight gained
during treatment, and eating disorder pathology between
patients with or without ROM. Chi-square tests were used
to compare patients with or without ROM in terms of
previous medical and/or psychiatric hospitalizations and
ethnicity, and to determine whether patients with bingeing
and/or purging behaviors at baseline were any more or less
likely to resume menses during treatment than patients
with a restricting subtype.
In an exploratory analysis, patients who achieved
ROM were compared across a range of physiological and
psychosocial variables to a subset of patients who gained
the appropriate amount of weight to expect menses to
return but failed to resume menses.
Results
Participant characteristics
Mean age of participants was 15.1 (SD = 2.2) years.
Seventy-seven percent self-identified as Caucasian, 12% as
Hispanic, 2% as African American, 4% as Asian, and 5% as
‘other’. Fifty-three (63%) patients met full DSM-IV-TRcriteria for AN, while 31 (37%) were categorized as partial
AN. There were no statistically significant differences
between patients with AN and partial AN in age, ethnicity,
LOI, and EDE subscale and global scores (all p’s > .13). As
expected, baseline percent EBW was lower for patients
with AN than for those with partial AN (M = 80.3, SD = 7.1
vs. M = 84.9, SD = 4.0, t(82) = −3.31, p < .001), while
patients with AN gained more weight (in lbs.) from baseline
to ROM compared to partial AN, even after controlling for
baseline percentage EBW (M = 15.5, SD = 10.3 vs.
10.6, SD = 9.4, F(2) = 4.74, p = .01). There was no difference
in terms of previous hospitalization for patients with AN
compared to those with partial AN (χ2(1) = 4.05, p = .06).
Resumption of menses
Mean percent EBW at baseline was 82.0 (SD = 6.5), with
67.9% (57/84) having ROM. Average percent EBW at
which ROM occurred was 94.9% (SD = 9.3) and average
weight gain required for ROM during treatment was
14.7 lbs. (SD = 10.8). (A table with the exact percent
EBW at which each participant experienced ROM is
available from the corresponding author upon request).
Mean session number at which ROM occurred was 13.5
(SD = 10.7), i.e., ~70% of standard FBT. There were no
differences in baseline age, ethnicity, or LOI between
patients with and without ROM. ROM was not associated
with percent EBW at baseline (t(82) = −0.77, NS), meaning
that patients who weighed less at baseline were no
less likely to resume menses during treatment than
patients at higher initial weights. Patients with partial
AN were more likely than full AN to resume menses
during treatment (χ2(1) = 3.82, p = .04). Patients with
binge/purge behaviors were no more likely to resume
menses than patients without those behaviors at
initial presentation (χ2(1) = 0.90, NS). Patient charac-
teristics for those with and those without ROM are
summarized in Table 1.
ROM Group versus no-ROM Group
Patients with ROM gained more weight during treatment
than those without ROM, but this difference was not statis-
tically significant (Mean = 94.9% EBW, SD = 9.3 vs. 91.6%
EBW, SD = 8.9). Patients with ROM had significantly higher
EDE Global Scores (p < .004), as well as Shape Concern
(p < .008) and Restraint (p < .002) subscale scores com-
pared to those without ROM. No other differences were
found between these two groups.
ROM versus no-ROM in patients with ≥ 95% EBW
Of the 27 patients who did not resume menses, 10
achieved ≥95% of EBW. In an exploratory analysis we
compared this subset of patients (n = 10) to those
with ROM after reaching 95% of EBW on LOI, per-
cent of EBW at baseline, amount of weight gained
Table 1 Baseline and End-of-Treatment Participant Characteristics with/without ROM (M, SD)
Variable ROM (n = 57) No ROM (n = 27) t p
Age in Years 15.21 (2.18) 14.99 (2.29) -0.44 .66
Percent EBW 82.39 (6.67) 81.2 (6.29) -0.77 .44
BMI 16.50 (1.29) 16.32 (1.44) -0.58 .57
Duration ill in months 16.15 (17.23) 12.21 (13.05) -0.92 .36
EDE Weight Concern 2.35 (1.68) 1.75 (1.51) -1.45 .15
EDE Shape Concern 2.89 (1.78) 1.67 (1.73) -2.75 .008
EDE Restraint 2.94 (1.59) 1.59 (1.86) -3.20 .002
EDE Eating Concern 1.89 (1.47) 1.40 (1.45) -1.33 .19
EDE Global Score 2.47 (1.44) 1.40 (1.41) -2.97 .004
Ethnicity ROM (Percent) No ROM (Percent) χ² p
Caucasian 80.7 70.4 1.12 .22
Hispanic 10.5 14.8 0.32 .41
African-American 0.0 7.4 4.31 .10
Asian 1.8 7.4 1.70 .24
Other/Not Specified 7.0 0.0 1.99 .21
Previous hospitalizations 28.3 24.0 0.16 .79
Restricting vs. Binge/Purge 60.0/40.0 70.4/29.6 0.90 .34
Key: ROM = Return of Menses; EBW = Expected Body Weight; BMI = Body Mass Index; EDE = Eating Disorder Examination; EOT = End-of-Treatment.
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Mann–Whitney U tests revealed significantly higher
EDE Shape Concern, Restraint, and Global Scores for
the group with ROM. There were no other differences
between these two groups (See Table 2).Table 2 Baseline participant characteristics with ROM versus
(M, SD)
Variable ROM (n = 57)
Age in years 15.21 (2.18)
Percent EBW 82.39 (6.67)
Weight gained during Tx (lbs.) 14.67 (10.83)
Duration ill in months 16.15 (17.23)
EDE Weight Concern 2.35 (1.68)
EDE Shape Concern 2.89 (1.78)
EDE Restraint 2.94 (1.59)
EDE Eating Concern 1.89 (1.47)







Previous Hosp (Med/Psych) 28.3
Key: ROM = Return of Menses; EBW = Expected Body Weight; EDE = Eating DisorderDiscussion
This study examined ROM in adolescent AN in relation to
percent EBW to estimate appropriate goal weights for this
patient population. All subjects were undergoing outpatient
FBT. We also examined demographic, physiological, andparticipants who reached 95% of EBW without ROM
95% no ROM (n = 10) z p
14.15 (2.04) -1.17 .24
85.51 (4.19) 1.53 .13
16.14 (6.57) 1.06 .29
12.67 (7.55) 0.23 .82
1.37 (0.81) -1.47 .14
0.81 (0.88) -3.18 <.01
0.73 (1.30) -3.17 <.01
1.16 (1.39) -1.34 .18
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occurred, on average, at 95% EBW suggesting that as a
minimum this weight target is necessary to restore menses
in adolescents, at least for those receiving an outpatient
course of FBT. Our findings support those of a prior study
which used pelvic ultrasound to demonstrate that ovarian
and uterine maturity in adolescent AN occur at 96.5%
EBW [35]. Together, these findings may suggest that previ-
ous goal weights of 90% EBW for this population might be
too low to support ROM [23]. In a recent study [1], it was
suggested that BMI percentiles between 14 and 39 could be
used to estimate treatment goal weight. Others reported
that about one third of AN adolescents with ROM did so
at weights above population averages [18], and in a
comparison of low weight AN patients without and with
menses, the latter consumed a more nutritionally ‘balanced’
diet than their amenorrheic counterparts [36,37]. In our
own exploratory analyses, about one third of patients with-
out ROM achieved 95% EBW or higher. Individual differ-
ences in weight trajectories should be taken into account,
as these data seem to indicate, as many patients may have
higher individual “setpoint” weights than the average EBW
calculations provide. These discrepancies, however, may
also be related to weight maintenance necessary to restore
menstrual function in adolescent AN as some patients will
only resume menses at weights >2 kg’s above the level that
supported menses prior to the onset of amenorrhea [23].
Together, these findings speak to why there is such a wide
range of weights at which menses resume.
It is of interest, though not surprising, that our results
differ from the often used adult standard of 90% EBW as
a treatment goal for AN [38], highlighting the need to
determine goal weights that are specific to adolescents.
For example, regular assessment, review, and adjustments
of goals weights are needed for this population, as these are
“moving targets” when growth in both height and weight
are expected during the pubertal years. Contrary to our
hypothesis, those with ROM reported more severe baseline
EDE psychopathology than those without ROM. This is
interesting as these groups were not shown to have other
differences in baseline characteristics, including percent
EBW and duration of illness. It is possible that FBT for ado-
lescent AN with more severe eating disorder symptomatol-
ogy differs from those who endorse fewer symptoms [39].
Although quite speculative, parents of adolescents
who are more impaired by their eating disorder are
perhaps more likely to appreciate the urgency and
severity of their child’s illness, and perhaps more
engaged in FBT. It is reasonable to assume that when
the disorder appears ‘less severe’ (i.e., physical and
psychological consequences are not as obvious and do
not appear imminently threatening), families may fail
to fully commit to FBT. There may also be a distinc-
tion in severity of the physical versus psychologicalsymptoms of AN that could account for differences
between those with or without ROM.
Some strengths and limitations should be noted. This
study is among the first to examine the weight (% EBW)
at which ROM occurs after a course of a manual-based
treatment modality (FBT). However, there was great vari-
ability in the number of treatment sessions at which menses
returned, demonstrating that some patients recommenced
menses after only a few sessions, while others required
much more treatment. Another strength of this study is the
examination of baseline psychological variables that correl-
ate with ROM during FBT. Limitations include a modest
sample size comprised mostly of Caucasian patients,
thereby restricting the generalizability of our findings. In
addition, there are limitations to using EBW based on the
CDC reference norms in children and adolescents, which
rely on cross-sectional data and do not take into account
the timing of puberty [30]. Girls who reach puberty earlier
or later than average may not follow the same pattern in
height and weight percentiles. In addition, menstrual status
data were collected using semi-structured interviews,
questionnaires, or self-report. Adolescents with AN may
choose not to fully disclose their current menstrual status,
or may not remember their menstrual history accurately. In
addition, irregular menstrual cycles are common among
adolescent females, especially during the first two years
post-menarche [40]. As such this may further complicate
the reason for the amenorrhea. No physiological or parent-
as-informant measures against which to validate self-
reported menstrual status were systematically employed.
Future studies could use more objective measures to
corroborate ROM, e.g., luteinizing hormones, follicle-
stimulating hormones, estradiol hormonal levels, and pelvic
ultrasound [1,35]. While all patients in this study were
treated with FBT, it does not inform us whether these find-
ings would generalize to patients receiving other forms of
treatment. In addition, information on menstrual threshold
weight was not available. It is possible that patients who lost
their menses at higher EBW percentages will need to gain
more weight to achieve ROM [1].
Conclusions
Findings from this study underscore the need for full
weight restoration based on EBW as a primary treatment
goal for the pediatric eating disorder populations. Several
factors are important to consider in setting appropriate
goal weights during weight restoration, e.g., past height
and weight percentiles, premorbid weight using menstrual
threshold or weight trajectory over time (if applicable),
sexual maturity, and age. When information concerning
the patient’s weight history is unavailable or conflicting,
our results suggest that aiming for at least 95% EBW is an
appropriate target for these patients in outpatient treat-
ment. Menstrual status is a frequently used measure of
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objective way to join percent EBW with a physical indicator
of biological health. Utilizing percent EBW in this way can
potentially lead to more accurate predictions of goal
weights during treatment. This does not negate that
percent EBW at which ROM occur differs among patients,
with some menstruating at body weights lower than 95%
EBW and others at body weights higher than this threshold.
Therefore, other clinical practice parameters, such as pelvic
maturity with ultrasonography and hormonal status, might
be more useful than percent EBW to identify target weights
for the ROM. Moreover, with growth and development and
over time, the EBW will change.
This is the first study to examine when ROM occurs
during FBT, and although tentative, it does provide
clinicians, and patients and families treated with FBT, a
clinical benchmark in that ROM occurred at 70% of the
standard number of sessions in this treatment. FBT is
manualized, has robust research support [24,34], and
eliminates the possibility of treatment group effects in this
sample. Consequently, we were able to identify baseline
psychosocial differences between patients with and without
ROM during a course of FBT. For now, this finding is
speculative, and potential reasons for this association might
be the large number of adolescent patients who fail to re-
port overvaluation of shape and weight and instead endorse
overvaluation of eating control. It should also be noted that
it is possible that feeling fat, or perceiving/experiencing
bloating in the pre-menstruation period, or experiencing
these feelings with weight gain alone, my intensify shape
concern. Future research will be vital to better understand
these differences and their implications for the treatment of
adolescents with AN.
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